[go: up one dir, main page]

SMT201700384T1 - Trattamento per allergia alle arachidi - Google Patents

Trattamento per allergia alle arachidi

Info

Publication number
SMT201700384T1
SMT201700384T1 SM20170384T SMT201700384T SMT201700384T1 SM T201700384 T1 SMT201700384 T1 SM T201700384T1 SM 20170384 T SM20170384 T SM 20170384T SM T201700384 T SMT201700384 T SM T201700384T SM T201700384 T1 SMT201700384 T1 SM T201700384T1
Authority
SM
San Marino
Prior art keywords
treatment
peanut allergy
allergy
peanut
Prior art date
Application number
SM20170384T
Other languages
English (en)
Inventor
Andrew Clark
Pamela Ewan
Original Assignee
Cambridge Univ Hospitals Nhs Foundation Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Univ Hospitals Nhs Foundation Trust filed Critical Cambridge Univ Hospitals Nhs Foundation Trust
Publication of SMT201700384T1 publication Critical patent/SMT201700384T1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM20170384T 2011-03-17 2012-03-16 Trattamento per allergia alle arachidi SMT201700384T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1104537.4A GB201104537D0 (en) 2011-03-17 2011-03-17 Treatment for peanut allergy
PCT/GB2012/050584 WO2012123759A1 (en) 2011-03-17 2012-03-16 Treatment for peanut allergy
EP12712344.6A EP2686013B1 (en) 2011-03-17 2012-03-16 Treatment for peanut allergy

Publications (1)

Publication Number Publication Date
SMT201700384T1 true SMT201700384T1 (it) 2017-09-07

Family

ID=44012746

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20170384T SMT201700384T1 (it) 2011-03-17 2012-03-16 Trattamento per allergia alle arachidi

Country Status (20)

Country Link
US (1) US9481716B2 (it)
EP (1) EP2686013B1 (it)
JP (1) JP2014509606A (it)
CN (1) CN103596589A (it)
AU (1) AU2012228033B2 (it)
CA (1) CA2867529C (it)
CY (1) CY1119074T1 (it)
DK (1) DK2686013T3 (it)
ES (1) ES2633319T3 (it)
GB (1) GB201104537D0 (it)
HR (1) HRP20170868T1 (it)
HU (1) HUE035385T2 (it)
LT (1) LT2686013T (it)
PL (1) PL2686013T3 (it)
PT (1) PT2686013T (it)
RS (1) RS56043B1 (it)
SG (2) SG193518A1 (it)
SI (1) SI2686013T1 (it)
SM (1) SMT201700384T1 (it)
WO (1) WO2012123759A1 (it)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2914286T3 (pl) * 2012-10-30 2022-01-31 Aravax Pty Ltd Nowe cząsteczki immunoterapeutyczne oraz ich zastosowania
JP6752140B2 (ja) * 2013-03-14 2020-09-09 アイミューン セラピューティクス,インコーポレイテッド 経口脱感作のための落花生処方物の製造
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
US11173206B2 (en) * 2013-03-15 2021-11-16 Sementis Limited Immune modulation
US20150343075A1 (en) * 2014-06-02 2015-12-03 Aimmune Therapeutics Placebo formulations and uses thereof
US11197896B2 (en) 2014-08-25 2021-12-14 Société des Produits Nestlé S.A. Egg protein formulations and methods of manufacture thereof
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10064936B2 (en) * 2015-02-20 2018-09-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US20160263212A1 (en) * 2015-02-23 2016-09-15 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens
US20170021010A1 (en) * 2015-07-21 2017-01-26 David Phillip ERSTEIN Allergy preventing dosage controlled food packets
US10856567B2 (en) * 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
IL272033B2 (en) 2017-07-18 2023-09-01 Before Brands Inc Methods for the preparation of mixed allergen preparations
US10603376B2 (en) 2017-08-30 2020-03-31 Roberto Garcia-Ibanez Immunotherapy for the treatment of allergic disease
MX2020004683A (es) * 2017-11-02 2020-08-13 Aimmune Therapeutics Inc Metodos de inmunoterapia oral.
GB201718342D0 (en) 2017-11-06 2017-12-20 Cambridge Allergy Ltd Allergenic protein formulations for immunotherapy
EP4545077A1 (en) * 2017-12-06 2025-04-30 Prollergy Corporation Composition and method for reducing allergic response
WO2019142189A1 (en) * 2018-01-16 2019-07-25 Tel Hashomer Medical Research Infrastructure And Services Ltd. Treatment and prevention of seed allergies
JP7526723B2 (ja) * 2018-05-22 2024-08-01 アラージェニス エルエルシー ピーナッツアレルギーを検出するためのペプチド及び方法
EP3829632A4 (en) 2018-07-27 2022-05-04 Société des Produits Nestlé S.A. Oral immunotherapy unit dose dispensing systems and methods
WO2020037151A1 (en) * 2018-08-16 2020-02-20 Aimmune Therapeutics, Inc. Peanut oral immunotherapy with maintenance dose
WO2020100024A1 (en) * 2018-11-12 2020-05-22 Murdoch Childrens Research Institute Method and system
JP2022514645A (ja) * 2018-12-20 2022-02-14 アイミューン セラピューティクス,インコーポレイテッド ピーナツ経口免疫療法において投与が欠落した場合の投与スケジュール
WO2020154476A1 (en) 2019-01-23 2020-07-30 Before Brands, Inc. Methods for making mixed allergen compositions
WO2020198024A1 (en) * 2019-03-22 2020-10-01 Aimmune Therapeutics, Inc. Systemic allergic response risk assessment in peanut oral immunotherapy
CN113966229A (zh) * 2019-05-10 2022-01-21 爱沐疗法公司 用于改善花生过敏患者的生活质量的方法
WO2020237181A1 (en) * 2019-05-23 2020-11-26 Aimmune Therapeutics, Inc. Methods of treating peanut allergy by oral immunotherapy with low-dose maintenance
BR112022009664A2 (pt) * 2019-11-20 2022-08-16 Nestle Sa Métodos e sistemas para gerenciamento de distribuição e tratamento de um fármaco oral de imunoterapia para alergia a alimentos
CA3161935A1 (en) * 2019-12-23 2021-07-01 Mimi Lai-Kuan Tang Oral immunotherapy comprising peanut allergens
US20230330169A1 (en) * 2019-12-23 2023-10-19 Prota Therapeutics Pty Ltd Pharmaceutical compositions
US20250342925A1 (en) * 2022-04-15 2025-11-06 Samsung Life Public Welfare Foundation Method for providing food allergy treatment service using oral immunotherapy, computer program stored in recording medium to implement method, and system
NL2033338B1 (en) 2022-10-17 2024-05-03 Vini Mini B V Prevention of tree nut and seed allergy in humans
WO2025080707A1 (en) * 2023-10-10 2025-04-17 Intrommune Therapeutics, Inc. Methods of inducing tolerance and reducing adverse reactions to one or more food allergens
WO2025109005A1 (en) * 2023-11-20 2025-05-30 Cambridge Allergy Ltd. Immunotherapy for treatment of allergy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003280324A1 (en) * 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product

Also Published As

Publication number Publication date
HUE035385T2 (en) 2018-05-02
SI2686013T1 (sl) 2017-10-30
EP2686013B1 (en) 2017-05-03
US20140093541A1 (en) 2014-04-03
US9481716B2 (en) 2016-11-01
SG10201602013SA (en) 2016-04-28
DK2686013T3 (en) 2017-07-10
CA2867529A1 (en) 2012-09-20
EP2686013A1 (en) 2014-01-22
LT2686013T (lt) 2017-07-10
CN103596589A (zh) 2014-02-19
SG193518A1 (en) 2013-10-30
HRP20170868T1 (hr) 2017-08-25
PT2686013T (pt) 2017-07-18
RS56043B1 (sr) 2017-09-29
GB201104537D0 (en) 2011-05-04
AU2012228033B2 (en) 2016-09-15
CA2867529C (en) 2022-08-23
PL2686013T3 (pl) 2017-10-31
JP2014509606A (ja) 2014-04-21
WO2012123759A1 (en) 2012-09-20
AU2012228033A1 (en) 2013-10-31
CY1119074T1 (el) 2018-01-10
ES2633319T3 (es) 2017-09-20

Similar Documents

Publication Publication Date Title
SG10201602013SA (en) Treatment for peanut allergy
IL227636A0 (en) Multimetric filtering
BR112013022820A2 (pt) método de tratamento
GB201119774D0 (en) IBS treatment
ZA201308117B (en) Avian-based treatment
GB201105523D0 (en) Treatment method
GB201121950D0 (en) Treatment process
GB201119171D0 (en) Gas treatment
GB201102283D0 (en) Treatment
GB2489207B (en) Waste treatment
GB201102284D0 (en) Treatment
GB201102271D0 (en) Treatment
GB201102276D0 (en) Treatment
GB201102277D0 (en) Treatment
GB201102282D0 (en) Treatment
GB201102274D0 (en) Treatment
GB201102273D0 (en) Treatment
GB201102288D0 (en) Treatment
GB201109119D0 (en) Treatment
GB201111247D0 (en) Treatment
GB201102272D0 (en) Treatment
GB201102266D0 (en) Treatment
GB201102267D0 (en) Treatment
GB201102270D0 (en) Treatment
GB201102268D0 (en) Treatment